Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: An examination of past Flaspohler Survey data to identify drivers of direct writer satisfaction with reinsurers.

Description: Book review of the latest edition (4th) of Life, Health, and Annuity Reinsurance by John Tiller, Jr and Denise Fagerberg Tiller

Description: Catastrophic exposure is on the rise owing to extreme weather and economic development of the past few years. Catastrophic claims peaked in 2017, but continue to pose a challenge to insurance markets. Global reinsurers seem to be well-capitalized despite the increase in CAT claims. But emerging insurance markets show a wide protection gap relative to more advance markets. Can reinsurance play a role in helping to narrow the gap? This article examines a few ideas.

Description: This article provides an update, as of September 2019, on the Reinsurance Section’s sponsored research in process and studies recently completed.

Description: Description of the world of reinsurance around the time the Reinsurance Section was formed.

Description: The observations and methodologies demonstrated in this article can help actuaries further analyze population mortality trends by causes of death and by socioeconomic status.

Description: Summary and discussion of the results of the 2002 Munich American annual survey on life reinsurance.

Description: As the title of this corner suggests, our industry has many challenges and issues yet to address. This article focuses on the directions for the industry and the Reinsurance Section, on multiple levels. This includes the development of an up-to-date directory of reinsurers by various lines of business and the upcoming Re-Focus Summit 2006 featuring risk management and reinsurance.

Description: Discussion of three aspects of GMDB— the retail product, the reinsurance players and the reinsurance techniques.